1800 202 8726
Side effects · Gefitinib

Raised Liver Enzymes on Gefitinib — What Your LFT Report Means

A raised liver result on gefitinib does not automatically mean your treatment will stop. Most enzyme rises are mild, caught on routine blood tests, and managed without interrupting your tablets. What matters is the grade of the rise and whether you have any symptoms alongside it.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026

  • Common and usually mild — Liver enzyme rises are one of the most frequently reported side effects of gefitinib, and most are low grade.
  • Caught on blood tests first — Most rises appear on routine monitoring before any symptoms develop, which is why regular LFTs matter.
  • Grade decides the response — Whether your oncologist pauses, adjusts or continues your gefitinib depends on how far above normal your results are.
  • Jaundice is always urgent — Yellowing of skin or eyes, dark urine, or right-sided pain means go to hospital that day, not your next appointment.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Speak to our team now

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Raised liver enzymes are one of the most common side effects of gefitinib. A mild rise, found on a routine blood test, does not mean your treatment will stop. NCCN and ASCO guidance grades the rise by how far it exceeds normal range, and most low-grade elevations are monitored closely rather than requiring treatment changes.

What to do between blood tests

  • Take gefitinib at the same time each day unless your oncologist has told you to pause.
  • Avoid alcohol completely while your liver enzymes are raised.
  • Tell your oncology team about every supplement, herbal remedy, or Ayurvedic preparation you are taking — some raise liver enzymes further.
  • Keep your blood test appointments even when you feel well — most rises are detected before any symptoms appear.
  • Write down any new symptoms between tests: tiredness, nausea, change in urine colour, or any yellowing of skin.
  • Do not stop gefitinib on your own without calling your team first.

If you are worried right now, call

Our helpline is answered by clinical staff. If a symptom is on the list above, do not wait for a callback — call, or go to your nearest emergency department.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Not sure whether this counts as an emergency?

Call the helpline. It is always better to check than to wait.

Book Free Consultation Call 1800 202 8726

How your oncologist grades a raised LFT on gefitinib

Grade (NCCN / CTCAE)What your report showsWhat this usually means for your treatment
Grade 1 — mildSlightly above the upper limit of normalContinue gefitinib. Blood tests repeated sooner than usual. Watch for new symptoms.
Grade 2 — moderateModerately above normalGefitinib may be paused briefly until levels return toward normal, then restarted.
Grade 3 — severeSignificantly above normalGefitinib is paused. Your team monitors closely. A restart may be possible once levels recover.
Grade 4 — life-threateningVery far above normal, or any jaundice or signs of liver failureGefitinib is usually stopped permanently. Go to hospital now if this applies to you.
Typically startsWeeks to months into treatmentMost rises are caught on routine blood tests before any symptoms develop.

Why does gefitinib affect the liver?

Gefitinib is processed through the liver. That processing can sometimes cause liver cells to become inflamed, which shows up on blood tests as raised AST, ALT, or bilirubin.

The rise is usually detected on a routine blood test rather than because of symptoms. This is why your oncology team schedules regular LFT monitoring from the start of treatment.

In most people the elevation is mild and settles with close monitoring. In a smaller proportion it is significant enough to need a treatment pause. The grade of the rise, not the number on the report alone, is what guides that decision.

Questions about raised liver enzymes on gefitinib

Can I carry on taking gefitinib if my liver test is abnormal?

Whether you continue depends on the grade of the rise and whether you have any symptoms alongside it. A mild rise is often managed while you stay on gefitinib, with more frequent monitoring. A moderate or severe rise may need a temporary pause. Do not stop or adjust your dose yourself — call your oncology team when you receive an abnormal result so they can review the full report and tell you exactly what to do.

Will my liver return to normal if gefitinib is paused?

In most cases, yes. Liver enzyme rises caused by gefitinib tend to improve once the drug is paused or stopped, and many people are able to restart at the same or a lower dose once levels recover. A small proportion of people do not recover quickly enough to restart, and a very severe or worsening rise may mean permanent discontinuation. Your oncologist will monitor the trend of your results, not just a single reading in isolation.

Are there supplements or foods that make liver enzymes worse on gefitinib?

Yes. Alcohol is the most important thing to avoid while your liver is already under strain from gefitinib. Several herbal products — including some Ayurvedic preparations, green tea extract in supplement form, and certain traditional medicines — are known to affect liver enzymes. Some prescription medicines from other specialists can also interact. Tell every member of your healthcare team what you are taking. The safest approach is to check before starting anything new, not after.

If gefitinib is paused, will my cancer grow during that time?

This is a reasonable concern, and it is worth asking your oncologist directly. A short pause of days to a few weeks is usually considered a manageable risk against the benefit of allowing liver levels to recover so treatment can safely resume. EGFR-mutated lung cancer that has been responding to gefitinib does not typically progress rapidly over a brief pause. What your oncologist will not do is leave you on a drug that is causing serious liver damage, because that risk is immediate and definite.

What should I tell my family if they are worried about the liver result?

Tell them that a raised result on a blood test is not the same as liver failure, and that it is being monitored specifically because of gefitinib. The liver has a large reserve capacity, and a mild rise in enzymes does not mean your liver has stopped working. The monitoring programme exists so that any meaningful change is caught early. The things that would genuinely need urgent action — jaundice, dark urine, severe abdominal pain — are unlikely to appear without warning, which is why regular blood tests are scheduled throughout your treatment.

Explore 75 more Lung Cancer Targeted Medicines topics

All Lung Cancer Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

How quickly do liver enzymes rise on gefitinib?

The rise can appear at any point after starting treatment, but it is most commonly seen within the first few months. Some people develop it earlier, some later, and some not at all. This is why your oncology team schedules blood tests throughout treatment rather than only at the start. There is no point at which the monitoring stops being relevant.

My ALT is high but my bilirubin is normal — does that mean it is less serious?

A raised ALT or AST alongside a normal bilirubin usually indicates a lower-grade liver reaction, and a normal bilirubin is a more reassuring finding than an elevated one. That said, neither result is something to interpret on your own — share the full report with your oncology team and let them grade it using the complete picture. Do not delay calling because one number looks acceptable to you.

Is a raised liver result a sign that gefitinib is not working against the cancer?

No. A liver enzyme rise is a side effect of how gefitinib is processed, not a sign of how well it is controlling the cancer. Some people with excellent tumour responses still develop raised LFTs, and some with no liver toxicity see their cancer progress. The two are unrelated. Your tumour response is assessed through scans, not through blood chemistry.

Can I have my LFT checked at a local lab rather than at my usual centre?

Ask your oncology team before doing this. For the result to be useful, your team needs to receive it promptly and compare it against your previous results using the same reference range. Results from different laboratories sometimes use slightly different normal ranges, which can make grading harder. If a local test is convenient, confirm in advance how your team wants the result sent to them.

What happens at the appointment after an abnormal LFT result?

Your oncologist will review the full liver panel alongside your symptoms, your other medications and supplements, and the trend from previous tests. They may order a repeat test within days rather than weeks, or refer you for an ultrasound if the pattern is unusual. The decision about whether to continue, pause or adjust gefitinib is made from all of that information together, not from a single abnormal number.

Call now Book free consultation